Literature DB >> 32763787

Radionuclide calibrator responses for 224Ra in solution and adsorbed on calcium carbonate microparticles.

Elisa Napoli1, Jeffrey T Cessna2, Leticia Pibida2, Ryan Fitzgerald2, Gro E Hjellum3, Denis E Bergeron4.   

Abstract

A suspension of 224Ra adsorbed onto CaCO3 microparticles shows promise for α-therapy of intracavitary micro-metastatic diseases. To facilitate accurate activity administrations, geometry-specific calibration factors for commercially available reentrant ionization chambers (ICs) have been developed for 224RaCl2 solutions and 224Ra adsorbed onto CaCO3 microparticles in suspension in ampoules, vials, and syringes. Ampoules and vials give IC responses consistent with each other to <1%. Microparticles attenuation leads to a ≈1% to ≈2.5% reduction in response in the geometries studied. Published by Elsevier Ltd.

Entities:  

Keywords:  Alpha therapy; Attenuation; Dose-response relationship; Geometry; Ionization chamber

Year:  2020        PMID: 32763787      PMCID: PMC7571540          DOI: 10.1016/j.apradiso.2020.109265

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  15 in total

1.  Experimental determinations of commercial 'dose calibrator' settings for nuclides used in nuclear medicine.

Authors:  B E Zimmerman; J T Cessna
Journal:  Appl Radiat Isot       Date:  2000-03       Impact factor: 1.513

2.  [Position of the German Society of Rheumatology on therapy of ankylosing spondylitis (AS) with radium chloride (224SpondylAT)].

Authors: 
Journal:  Z Rheumatol       Date:  2001-04       Impact factor: 1.372

3.  An automated ionization chamber for secondary radioactivity standards.

Authors:  R Fitzgerald
Journal:  Appl Radiat Isot       Date:  2010-01-19       Impact factor: 1.513

4.  An update on 'dose calibrator' settings for nuclides used in nuclear medicine.

Authors:  Denis E Bergeron; Jeffrey T Cessna
Journal:  Nucl Med Commun       Date:  2018-06       Impact factor: 1.690

5.  Antitumor Activity of Novel Bone-seeking, α-emitting 224Ra-solution in a Breast Cancer Skeletal Metastases Model.

Authors:  Asta Juzeniene; Jenni Bernoulli; Mari Suominen; Jussi Halleen; Roy Hartvig Larsen
Journal:  Anticancer Res       Date:  2018-04       Impact factor: 2.480

6.  Radium Ra 223 dichloride injection: U.S. Food and Drug Administration drug approval summary.

Authors:  Paul G Kluetz; William Pierce; V Ellen Maher; Hui Zhang; Shenghui Tang; Pengfei Song; Qi Liu; Martin T Haber; Eldon E Leutzinger; Ali Al-Hakim; Wei Chen; Todd Palmby; Elleni Alebachew; Rajeshwari Sridhara; Amna Ibrahim; Robert Justice; Richard Pazdur
Journal:  Clin Cancer Res       Date:  2013-11-04       Impact factor: 12.531

7.  Primary standardization of 224Ra activity by liquid scintillation counting.

Authors:  Elisa Napoli; Jeffrey T Cessna; Ryan Fitzgerald; Leticia Pibida; Ronald Collé; Lizbeth Laureano-Pérez; Brian E Zimmerman; Denis E Bergeron
Journal:  Appl Radiat Isot       Date:  2019-10-11       Impact factor: 1.513

8.  Revision of the NIST Standard for (223)Ra: New Measurements and Review of 2008 Data.

Authors:  B E Zimmerman; D E Bergeron; J T Cessna; R Fitzgerald; L Pibida
Journal:  J Res Natl Inst Stand Technol       Date:  2015-03-11

9.  Therapeutic Effect of α-Emitting 224Ra-Labeled Calcium Carbonate Microparticles in Mice with Intraperitoneal Ovarian Cancer.

Authors:  Sara Westrøm; Tina B Bønsdorff; Øyvind S Bruland; Roy H Larsen
Journal:  Transl Oncol       Date:  2018-01-28       Impact factor: 4.243

10.  Ra-224 labeling of calcium carbonate microparticles for internal α-therapy: Preparation, stability, and biodistribution in mice.

Authors:  Sara Westrøm; Marion Malenge; Ida Sofie Jorstad; Elisa Napoli; Øyvind S Bruland; Tina B Bønsdorff; Roy H Larsen
Journal:  J Labelled Comp Radiopharm       Date:  2018-03-12       Impact factor: 1.921

View more
  1 in total

1.  Ra-224 activity, half-life, and 241 keV gamma ray absolute emission intensity: A NIST-NPL bilateral comparison.

Authors:  Denis E Bergeron; Sean M Collins; Leticia Pibida; Jeffrey T Cessna; Ryan Fitzgerald; Brian E Zimmerman; Peter Ivanov; John D Keightley; Elisa Napoli
Journal:  Appl Radiat Isot       Date:  2020-12-31       Impact factor: 1.513

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.